Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Prepaid Assets (2016 - 2025)

Lisata Therapeutics filings provide 13 years of Prepaid Assets readings, the most recent being $1.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets fell 28.2% year-over-year to $1.7 million, compared with a TTM value of $1.7 million through Dec 2025, down 28.2%, and an annual FY2025 reading of $1.7 million, down 28.2% over the prior year.
  • Prepaid Assets hit $1.7 million in Q4 2025 for Lisata Therapeutics, down from $2.1 million in the prior quarter.
  • The five-year high for Prepaid Assets was $4.2 million in Q1 2024, with the low at $1.7 million in Q4 2025.
  • Median Prepaid Assets over the past 3 years was $2.6 million (2023), compared with a mean of $2.9 million.
  • The largest YoY upside for Prepaid Assets was 13.02% in 2025 against a maximum downside of 51.69% in 2025.
  • Year by year, Prepaid Assets stood at $3.4 million in 2023, then dropped by 28.21% to $2.4 million in 2024, then dropped by 28.2% to $1.7 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $1.7 million, $2.1 million, and $2.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.